Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study.

Rao A, Standing JF, Naik S, Savage MO, Sanderson IR.

BMJ Open. 2013 May 28;3(5). pii: e002737. doi: 10.1136/bmjopen-2013-002737.

2.

Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.

Beattie RM, Camacho-Hübner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO.

Clin Endocrinol (Oxf). 1998 Oct;49(4):483-9.

PMID:
9876346
3.

Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.

Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO.

Clin Endocrinol (Oxf). 1999 Dec;51(6):787-92.

PMID:
10619985
4.

Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.

Camacho-Hübner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J, Rogol A, Allan G, Sommer A, Savage MO.

J Clin Endocrinol Metab. 2006 Apr;91(4):1246-53.

PMID:
16403822
5.

Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.

Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG.

J Clin Endocrinol Metab. 1997 Feb;82(2):629-33.

PMID:
9024266
7.

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO.

J Clin Endocrinol Metab. 1999 May;84(5):1611-6.

PMID:
10323388
8.

Administration of human recombinant insulin-like growth factor-I in critically ill patients.

Yarwood GD, Ross RJ, Medbak S, Coakley J, Hinds CJ.

Crit Care Med. 1997 Aug;25(8):1352-61.

PMID:
9267949
9.

Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.

Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, Minuto F.

J Clin Endocrinol Metab. 1998 Oct;83(10):3534-41.

PMID:
9768660
11.

Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.

Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46.

PMID:
10209561
12.
13.

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.

Dig Liver Dis. 2004 May;36(5):342-7.

PMID:
15191204
14.

Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.

Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE; GH Insensitivity Syndrome Collaborative Group..

J Clin Endocrinol Metab. 2007 Mar;92(3):902-10.

PMID:
17192294
15.

Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.

Maghnie M, Barreca A, Ventura M, Tinelli C, Ponzani P, De Giacomo C, Maggiore G, Severi F.

Clin Endocrinol (Oxf). 1998 Jun;48(6):747-55.

PMID:
9713564
16.

Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.

Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR.

J Clin Endocrinol Metab. 1992 Jul;75(1):30-6.

PMID:
1377706
17.
18.

Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.

Woods KA, Camacho-Hübner C, Bergman RN, Barter D, Clark AJ, Savage MO.

J Clin Endocrinol Metab. 2000 Apr;85(4):1407-11.

PMID:
10770174
19.

Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group..

J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6.

PMID:
17356043
20.

[Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].

Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.

Zhonghua Er Ke Za Zhi. 2009 Jan;47(1):48-52. Chinese.

PMID:
19573383
Items per page

Supplemental Content

Support Center